Ignite Creation Date:
2024-05-05 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00539578
Status:
COMPLETED
Last Update Posted:
2015-11-01
First Post:
2007-10-01
Brief Title:
Treatment of Patients With Anxiety Disorder 0777-022
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Double-Blind Mulitcenter Placebo-Controlled Flexible-Dose Replicate Study of MK0777 Gel Extrusion Module GEM 3 mg BID to 8 mg BID in the Treatment of Outpatients With Generalized Anxiety Disorder
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to examine the safety and efficacy of MK0777 during treatment for Generalized Anxiety Disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_622 | None | None | None |
| MK0777-022 | None | None | None |